<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">aids</journal-id><journal-title-group><journal-title xml:lang="ru">ВИЧ-инфекция и иммуносупрессии</journal-title><trans-title-group xml:lang="en"><trans-title>HIV Infection and Immunosuppressive Disorders</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2077-9828</issn><publisher><publisher-name>Baltic Medical Education Center</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.22328/2077-9828-2022-14-3-94-99</article-id><article-id custom-type="elpub" pub-id-type="custom">aids-738</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ ПРАКТИКА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL PRACTICE</subject></subj-group></article-categories><title-group><article-title>Жалобы больного как предикторы неблагоприятного исхода при туберкулезе с ВИЧ-инфекцией</article-title><trans-title-group xml:lang="en"><trans-title>Complaints of a patient — as predictors of adverse outcomes in tuberculosis with HIV infection</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Боровицкий</surname><given-names>В. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Borovitsky</surname><given-names>V. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Боровицкий Владислав Семенович — кандидат медицинских наук, врач-фтизиатр</p><p>613040, Кировская область, г. Кирово-Чепецк, проезд Западный</p></bio><bio xml:lang="en"><p>Kirovo-Chepetsk</p></bio><email xlink:type="simple">qwertyuiop54@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Филиал «Туберкулезная больница» Медико-санитарной части № 43</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Branch «Tuberculosis hospital» of Medical-sanitary part No. 43</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>10</day><month>11</month><year>2022</year></pub-date><volume>14</volume><issue>3</issue><fpage>94</fpage><lpage>99</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Боровицкий В.С., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Боровицкий В.С.</copyright-holder><copyright-holder xml:lang="en">Borovitsky V.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://hiv.bmoc-spb.ru/jour/article/view/738">https://hiv.bmoc-spb.ru/jour/article/view/738</self-uri><abstract><sec><title>Цель</title><p>Цель. Выявить жалобы больного при поступлении в стационар, статистически значимо связанные с неблагоприятным исходом при туберкулезе с ВИЧ-инфекцией с наибольшей чувствительностью и специфичностью.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Обследованы 363 больных с туберкулезом и ВИЧ-инфекцией. В первую группу вошли 59 (16,3%) пациентов с неблагоприятным исходом заболевания, во вторую группу — 304 пациента (83,7%) с благоприятным исходом. Методы: клинические, лабораторные, микробиологические, статистические: анализ парных таблиц сопряженности по критерию Пирсона, количественных признаков по критерию Манна–Уитни, логистическая регрессия.</p><p>Результаты и их обсуждение. Наибольшее отношение шансов чувствительности и специфичности среди жалоб больного туберкулезом с ВИЧ-инфекцией, высоковероятных по риску наступления неблагоприятного исхода (р&lt;0,0001), имеют лихорадка — 26,8, 93,2% и 66,1%, жидкий стул — 25,4, 40,7% и 97,4%, похудание — 18,8, 72,9% и 87,5%, снижение аппетита — 17,0, 69,5% и 88,2%, одышка — 15,6, 79,7% и 79,9%, слабость — 8,7, 91,5% и 44,7%, головные боли — 7,4, 49,2% и 88,5% соответственно. Таким образом, при отсутствии других жалоб риск наступления неблагоприятного исхода у больного туберкулезом с ВИЧ-инфекцией по сравнению с больным без данной жалобы увеличивается для лихорадки в 26,8 раза, для жидкого стула — в 25,4 раза, для похудания — в 18,8 раза, для снижения аппетита — в 17,0 раз, для одышки — в 15,6 раза, для слабости — в 8,7 раза, для головной боли — в 7,4 раза. </p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective. To detect patient’s complaints on admission to the hospital, statistically important with adverse outcome in tuberculosis with HIV infection, most sensitivity and specificity.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. 363 patients were examined with tuberculosis and HIV infection. The first group included 59 (16,3%) patients with adverse disease outcome, the second group contained 304 patients (83,7%) with favorable outcome. Methods: clinical, laboratory, microbiological, statistical: analysis of pairwise contingency tables by Pearson’s criterion, Mann-Whitney test on quantitative characteristics, logistic regression.</p></sec><sec><title>Results and discussion</title><p>Results and discussion. The highest odds ratio of sensitivity and specificity among HIV and tuberculosis patient’s complaints, highly probable on risk of adverse outcome (р&lt;0,0001), has fever — 26,8, 93,2% and 66,1%, loose stools — 25,4, 40,7% and 97,4%, weight loss — 18,8, 72,9% and 87,5%, loss of appetite — 17,0, 69,5% and 88,2%, shortness of breath — 15,6, 79,7% and 79,9%, weakness — 8,7, 91,5% and 44,7%, headache — 7,4, 49,2% and 88,5% accordingly. Thus, in the absence of other complaints the risk of adverse outcome in a patient with HIV and tuberculosis, compared to a patient with no such complaints increases for fever 26,8 times, for loose stools — 25,4 times, for weight loss — 18,8 times, for loss of appetite — 17,0 times, for shortness of breath —15,6 times, for weakness — 8,7 times, for headache — 7,4 times.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>туберкулез</kwd><kwd>ВИЧ-инфекция</kwd><kwd>неблагоприятный исход</kwd><kwd>факторы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>tuberculosis</kwd><kwd>HIV infection</kwd><kwd>adverse outcome</kwd><kwd>factors</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Mugusi S.F., Ngaimisi E., Janabi M.Y., Mugusi F.M., Minzi O.M., Sasi P.G., Bakari M., Lindquist L., Aklillu E., Sandstrom E.G. Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania // Antivir Ther. 2012. Vol. 17, No. 2. P. 265–274. doi: 10.3851/IMP1956.</mixed-citation><mixed-citation xml:lang="en">Mugusi S.F., Ngaimisi E., Janabi M.Y., Mugusi F.M., Minzi O.M., Sasi P.G., Bakari M., Lindquist L., Aklillu E., Sandstrom E.G. Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania // Antivir Ther. 2012. Vol. 17, No. 2. P. 265–274. doi: 10.3851/IMP1956.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Njuguna I.N., Cranmer L.M., Wagner A.D., LaCourse S.M., Mugo C., Benki-Nugent S., Richardson B.A., Stern J., Maleche-Obimbo E., Wamalwa D.C., John-Stewart G. Brief Report: Cofactors of Mortality Among Hospitalized HIV-Infected Children Initiating Antiretroviral Therapy in Kenya // J. Acquir. Immune Defic. Syndr. 2019. Vol. 81, No. 2. P. 138–144. doi: 10.1097/QAI.0000000000002012.</mixed-citation><mixed-citation xml:lang="en">Njuguna I.N., Cranmer L.M., Wagner A.D., LaCourse S.M., Mugo C., Benki-Nugent S., Richardson B.A., Stern J., Maleche-Obimbo E., Wamalwa D.C., John-Stewart G. Brief Report: Cofactors of Mortality Among Hospitalized HIV-Infected Children Initiating Antiretroviral Therapy in Kenya // J. Acquir. Immune Defic. Syndr. 2019. Vol. 81, No. 2. P. 138–144. doi: 10.1097/QAI.0000000000002012.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Chan C.K., Wong K.H., Lee M.P., Chan K.C., Leung C.C., Leung E.C., Chan W.K., Mak I.K. Risk factors associated with 1-year mortality among patients with HIV-associated tuberculosis in areas with intermediate tuberculosis burden and low HIV prevalence // Hong Kong Med J. 2018. Vol. 24, No. 5. P. 473–483.</mixed-citation><mixed-citation xml:lang="en">Chan C.K., Wong K.H., Lee M.P., Chan K.C., Leung C.C., Leung E.C., Chan W.K., Mak I.K. Risk factors associated with 1-year mortality among patients with HIV-associated tuberculosis in areas with intermediate tuberculosis burden and low HIV prevalence // Hong Kong Med J. 2018. Vol. 24, No. 5. P. 473–483.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Gamboa-Acuna B., Guillen-Zambrano R., Lizzetti-Mendoza G., Soto A., Lucchetti-Rodriguez A. Factors associated to survival in patients with HIV-TB in the Department of Infectious Diseases of the Arzobispo Loayza National Hospital, Peru, since 2004 to 2012 // Rev. Chilena Infectol. 2018. Vol. 35, No. 1. P. 41–48.</mixed-citation><mixed-citation xml:lang="en">Gamboa-Acuna B., Guillen-Zambrano R., Lizzetti-Mendoza G., Soto A., Lucchetti-Rodriguez A. Factors associated to survival in patients with HIV-TB in the Department of Infectious Diseases of the Arzobispo Loayza National Hospital, Peru, since 2004 to 2012 // Rev. Chilena Infectol. 2018. Vol. 35, No. 1. P. 41–48.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Naidoo K., Yende-Zuma N., Augustine S. A retrospective cohort study of body mass index and survival in HIV infected patients with and without TB co-infection // Infect. Dis. Poverty. 2018. Vol. 7, No. 1. P. 35.</mixed-citation><mixed-citation xml:lang="en">Naidoo K., Yende-Zuma N., Augustine S. A retrospective cohort study of body mass index and survival in HIV infected patients with and without TB co-infection // Infect. Dis. Poverty. 2018. Vol. 7, No. 1. P. 35.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Demitto F.O., Schmaltz C.A.S., Sant’Anna F.M., Arriaga M.B., Andrade B.B., Rolla V.C. Predictors of early mortality and effectiveness of anti-retroviral therapy in TB-HIV patients from Brazil // PLoS One. 2019. Vol. 14, No. 6. P. 0217014.</mixed-citation><mixed-citation xml:lang="en">Demitto F.O., Schmaltz C.A.S., Sant’Anna F.M., Arriaga M.B., Andrade B.B., Rolla V.C. Predictors of early mortality and effectiveness of anti-retroviral therapy in TB-HIV patients from Brazil // PLoS One. 2019. Vol. 14, No. 6. P. 0217014.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Sattler F.R., Chelliah D., Wu X., Sanchez A., Kendall M.A., Hogg E., Lagat D., Lalloo U., Veloso V., Havlir D.V., Landay A. Biomarkers Associated with Death After Initiating Treatment for Tuberculosis and HIV in Patients with Very Low CD4 Cells // Pathog. Immun. 2018. Vol. 3, No. 1. P. 46–62.</mixed-citation><mixed-citation xml:lang="en">Sattler F.R., Chelliah D., Wu X., Sanchez A., Kendall M.A., Hogg E., Lagat D., Lalloo U., Veloso V., Havlir D.V., Landay A. Biomarkers Associated with Death After Initiating Treatment for Tuberculosis and HIV in Patients with Very Low CD4 Cells // Pathog. Immun. 2018. Vol. 3, No. 1. P. 46–62.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rossetto M., Brand É.M., Teixeira L.B. Factors associated with hospitalization and death among TB/HIV co-infected persons in Porto Alegre, Brazil // PLoS One. 2019. Vol. 14, No. 1. P. 0209174.</mixed-citation><mixed-citation xml:lang="en">Rossetto M., Brand É.M., Teixeira L.B. Factors associated with hospitalization and death among TB/HIV co-infected persons in Porto Alegre, Brazil // PLoS One. 2019. Vol. 14, No. 1. P. 0209174.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ланг Т.А., Сесик М. Как описывать статистику в медицине. Аннотированное руководство для авторов, редакторов и рецензентов / пер. с англ под ред. В. П. Леонова. М.: Практическая медицина, 2011. 480 с.: ил.</mixed-citation><mixed-citation xml:lang="en">Lang T.A., Sesik M. How to describe statistics in medicine. Annotated guide for authors, editors and reviewers, translated from English ed. V. P. Leonova. Moscow: Publishing house Practical medicine, 2011, 480 p.: il. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Петри А., Сэйбин К. Наглядная медицинская статистика / пер. с англ. под ред. В. П. Леонова. 2-е изд., перераб. и доп. М.: ГЭОТАРМедиа, 2009. 168 с.: ил.</mixed-citation><mixed-citation xml:lang="en">Petri A., Seibin K. Visual medical statistics, translated from English ed. V. P. Leonova. 2nd ed., rev. and add. Moscow: Publishing house GEOTAR-Media, 2009, 168 p.: il. (In Russ.).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
